These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit. Chastre J; Luyt CE; Combes A; Trouillet JL Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519 [TBL] [Abstract][Full Text] [Related]
25. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit? Wahl WL; Franklin GA; Brandt MM; Sturm L; Ahrns KS; Hemmila MR; Arbabi S J Trauma; 2003 Apr; 54(4):633-8; discussion 638-9. PubMed ID: 12707523 [TBL] [Abstract][Full Text] [Related]
26. Importance, morbidity, and mortality of pneumonia in the surgical intensive care unit. Barie PS Am J Surg; 2000 Feb; 179(2A Suppl):2S-7S. PubMed ID: 10802251 [TBL] [Abstract][Full Text] [Related]
27. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS). Gastmeier P; Sohr D; Geffers C; Behnke M; Daschner F; Rüden H Infection; 2005 Apr; 33(2):50-5. PubMed ID: 15827870 [TBL] [Abstract][Full Text] [Related]
28. Nosocomial pneumonia in the noncritical care setting. Whitson B; Grier L; Campbell GD Curr Opin Pulm Med; 1995 May; 1(3):188-93. PubMed ID: 9363052 [TBL] [Abstract][Full Text] [Related]
29. [Update pneumonia 2012]. Pletz MW; Ewig S; Lange C; Welte T; Höffken G Dtsch Med Wochenschr; 2012 Nov; 137(44):2265-80; quiz 2281-4. PubMed ID: 23093399 [TBL] [Abstract][Full Text] [Related]
30. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. El-Solh AA; Aquilina AT; Dhillon RS; Ramadan F; Nowak P; Davies J Am J Respir Crit Care Med; 2002 Oct; 166(8):1038-43. PubMed ID: 12379545 [TBL] [Abstract][Full Text] [Related]
31. Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy. Lee SC; Hua CC; Yu TJ; Shieh WB; See LC Int J Clin Pract; 2005 Jan; 59(1):39-45. PubMed ID: 15707463 [TBL] [Abstract][Full Text] [Related]
32. Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy. Franzetti F; Grassini A; Piazza M; Degl'innocenti M; Bandera A; Gazzola L; Marchetti G; Gori A Infection; 2006 Feb; 34(1):9-16. PubMed ID: 16501896 [TBL] [Abstract][Full Text] [Related]
33. Considerations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia. Bradley JS Clin Infect Dis; 2010 Aug; 51 Suppl 1():S136-43. PubMed ID: 20597664 [TBL] [Abstract][Full Text] [Related]
34. [Microbiological monitoring of ventilator-associated pneumonia in an intensive care unit]. Joost I; Lange C; Seifert H Dtsch Med Wochenschr; 2010 Feb; 135(5):197-202. PubMed ID: 20104440 [TBL] [Abstract][Full Text] [Related]
35. A probabilistic approach to improved antibiotic therapy. de Bruijn N; Lucas P; Schurink K; Hoepelman A Stud Health Technol Inform; 1999; 68():690-5. PubMed ID: 10724980 [TBL] [Abstract][Full Text] [Related]
36. The role of new therapies for severe community-acquired pneumonia. Restrepo MI; Anzueto A Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331 [TBL] [Abstract][Full Text] [Related]
37. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis. Rosenthal VD; Guzman S; Migone O; Safdar N Am J Infect Control; 2005 Apr; 33(3):157-61. PubMed ID: 15798670 [TBL] [Abstract][Full Text] [Related]
38. [Quality of care assessment and nosocomial pneumonia in the intensive care unit]. Girault C; Tamion F; Beduneau G Rev Mal Respir; 2006 Apr; 23 Suppl 2():4S27-4S43. PubMed ID: 16733399 [TBL] [Abstract][Full Text] [Related]
39. Current guidelines for the treatment of severe pneumonia and sepsis. Bodmann KF Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664 [TBL] [Abstract][Full Text] [Related]